Gl. Winters et al., IMMEDIATE EVALUATION OF ENDOMYOCARDIAL BIOPSIES FOR CLINICALLY SUSPECTED REJECTION AFTER HEART-TRANSPLANTATION, Circulation, 89(5), 1994, pp. 2079-2084
Background Acute rejection may be suspected in heart transplant recipi
ents in the setting of new onset of clinical symptoms or alterations i
n cardiac function. Immediate diagnosis may be obtained by performing
a frozen section on endomyocardial biopsy (EMB) specimens. However, li
ttle is known about the indications for, and the diagnostic reliabilit
y of, this procedure. Methods and Results EMBs with frozen section (n=
98) from 65 of 214 consecutive orthotopic heart transplant recipients
were reviewed and divided into early (less than or equal to 45 days; n
=47) and late (>45 days; n=51) posttransplant periods. Frozen section
diagnoses (($) over bar x=1.5 EMB samples) were compared with correspo
nding permanent section diagnoses ($) over bar x=4.4 EMB samples), and
clinical indications were analyzed. Comparison of frozen and permanen
t section interpretation revealed concordant pathological processes-re
jection (n=31) versus no rejection (n=37) versus ischemic injury (n=20
) -in 88 of 98 (90%) cases. Discordant pathological processes on froze
n versus permanent section in 10 of 98 (10%) cases could be attributed
to ischemic injury (n=5), sampling (n=4), and infection (n=1). In the
92 cases with defined clinical indications, the indication and number
of EMBs positive for rejection early and late after transplantation w
ere arrhythmia: 2 of 12 early, 4 of 10 late; congestive heart failure:
1 of 2 early, 5 of 12 late; fever: 0 of 2 early, 1 of 4 late; echo ab
normality: 0 of 5 early, 0 of 1 late; syncope: 1 of 5 early, 0 of 1 la
te; hypotension: 1 of 3 early, 1 of 2 late; noncompliance: 0 of 0 earl
y, 4 of 5 late; more than one pf the above: 3 of 7 early, 2 of 5 late;
other: 1 of 7 early, 1 of 9 late; total: 9 of 43 early, 18 of 49 late
. Conclusions Frozen section on EMB specimens accurately reflected the
permanent section diagnosis in 90% of cases. No specific clinical ind
ication predicted EMB rejection positivity with high sensitivity in ei
ther the early or late posttransplant periods.